Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis

Mostrar otras versiones (1)

BACKGROUND: The effect of immunomodulatory therapy with tocilizumab for coronavirus disease 2019 (COVID-19) in real-life clinical practice remains controversial. METHODS: Single-center retrospective matched cohort analysis including 47 consecutive patients treated with intravenous tocilizumab for se...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Ruiz, Mario, López-Medrano, Francisco, Carretero, Octavio, Parra, Patricia, Ruiz-Merlo, Tamara, Aguado, José María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260823/
https://www.ncbi.nlm.nih.gov/pubmed/34243954
http://dx.doi.org/10.1016/j.medcli.2021.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260823/
https://www.ncbi.nlm.nih.gov/pubmed/34243954
http://dx.doi.org/10.1016/j.medcli.2021.06.014

Ejemplares similares